(1)
Khan, S.; Yetiskul, E.; Khattar, G.; Ghada, A.; Afif, S.; Khan, M. W. Z.; Manchandani, U. Failure of the PD-1 Blocking Agent Pembrolizumab to Benefit a Patient With Renal Squamous Cell Cancer. EJCRIM 2024, 11 (7). https://doi.org/10.12890/2024_004619.